Being more physically fit appears to slow down damage to the brain’s memory centers in the early stages of Alzheimer’s disease, according to a study conducted by researchers from the University of Kansas Medical Center and presented at the Alzheimer’s Association International Conference on Alzheimer’s Disease in Chicago.

“This is the first study to get an inside look into specifically where these changes occur in the brain,” lead researcher Robyn Honea said. “We’re able to locate the changes associated with fitness to the actual memory region, the hippocampus, which is a key area for Alzheimer’s-related atrophy.”

Researchers conducted magnetic resonance imaging (MRI) brain scans on 60 adults over the age of 60 who were in the early stages of Alzheimer’s disease, along with 56 who did not have any form of dementia. All participants also took part in tests of oxygen consumption during a treadmill exercise, as a measure of overall cardiovascular fitness. Read the rest of this entry »

Looking to make a change and lose some weight? I have reviewed the top diet on the internet and you can go and read over 200 comments people have made about why this diet has worked well for them, as well as some of the problems.

Tags: Alzheimer's, Alzheimer's Association, Alzheimer's disease, Association's Medical and Scientific Advisory Council, Chairman, Chicago, dementia, lead researcher, magnetic resonance imaging, MRI, Robyn Honea, Sam Gandy, University of Kansas Medical Center, www.reuters.com

The Daily Mail in England has this very interesting story that seems to give hope to the millions of people worldwide that suffer from Alzheimers disease.

Doctors are calling for a clinical trial of an experimental drug treatment that it is claimed can reverse the symptoms of Alzheimer’s disease “in minutes”.

U.S. researchers say the treatment allowed an 82-year- old sufferer to recognize his wife for the first time in years.

In the UK, specialists believe the claims should be properly tested as only a few patients have been treated so far.
The treatment involves injecting a drug called Enbrel – which is normally used to treat arthritis – into the spine at the neck. Read the rest of this entry »

Tags: Alzheimer's, Alzheimer's disease, Alzheimer's Research Trust, Alzheimer's Society, ankylosing spondylitis, arthritis, California, chief executive, cough, diabetes, director, Edward Tobinick, Enbrel, experimental therapy, fever, head of research, immune disease, inflammation, Institute for Neurological Research, Institute of Neurological Research, juvenile idiopathic arthritis, Los Angeles, Marvin Miller, necrosis, nurse, professor, psoriasis, psoriatic arthritis, Rebecca Wood, rheumatoid arthritis, Serious infections, Susanne Sorensen, TB, tuberculosis, tumor, tumour, United Kingdom, United States, University of California Los Angeles